Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Mid-range Performer

Download real time

1959.20 6.50 (0.33%)

53.60% Gain from 52W Low

533.0K

NSE+BSE Volume

NSE 01 Oct, 2025 3:31 PM (IST)

Dividend

Glenmark Pharmaceuticals Ltd. has an upcoming dividend of ₹2.50 per share due on 03 Oct 2025 See details

Glenmark Pharmaceuticals Ltd. quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents